Trial Profile
A non randomised phase II trial of sequential therapy of imiquimod (Aldara) followed by photodynamic therapy for vulval intraepithelial neoplasia
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Oct 2005
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Vulvar intraepithelial neoplasia
- Focus Therapeutic Use
- 27 Oct 2005 New trial record.